rotaviru
one
main
caus
acut
diarrhea
enter
infant
current
studi
underway
assess
use
probiot
improv
rotaviru
vaccin
protect
previou
work
demonstr
probiot
strain
bifidobacterium
longum
subsp
infanti
cect
abl
hinder
rotaviru
replic
vitro
vivo
present
studi
take
systemat
approach
order
identifi
molecul
directli
involv
rotaviru
inhibit
supernat
proteas
digest
reveal
proteinac
natur
activ
substanc
fact
molecul
respons
inhibit
rotaviru
replic
releas
supernat
follow
purif
cation
exchang
chromatographi
activ
fraction
obtain
function
compound
identifi
acid
peptid
mhqphqplppt
name
peptid
molecular
mass
kda
function
verifi
use
synthes
peptid
wa
ito
rotaviru
infect
cell
line
final
proteas
activ
detect
b
longum
subsp
infanti
cect
supernat
releas
peptid
preliminari
identif
proteas
also
includ
studi
group
rotaviru
one
major
caus
acut
gastroenter
infant
young
children
lead
estim
million
hospit
per
year
parashar
et
al
despit
administr
rotaviru
vaccin
rotaviru
still
account
estim
hospit
admiss
diarrheal
diseas
europ
william
et
al
howev
hospit
older
children
adult
diarrhea
greatli
decreas
introduct
infant
rotaviru
vaccin
suggest
rotaviru
episod
transmit
infant
lopman
et
al
rotavirus
transmit
fecalor
rout
induc
diarrhea
due
malabsorpt
infect
epitheli
cell
intestin
mucosa
kapikian
et
al
increas
intestin
motil
istrat
et
al
mechan
underli
diarrhea
includ
secondari
malabsorpt
patchi
lesion
villou
atrophi
disrupt
tight
junction
small
intestin
alter
ion
channel
transport
due
secret
neurotransmitt
hagbom
et
al
toxic
hodg
gill
activ
enter
nervou
system
lundgren
et
al
express
aquaporin
cao
et
al
process
character
profus
diarrhea
caus
sever
dehydr
case
nonintervent
lead
death
parashar
et
al
sever
vaccin
develop
demonstr
differ
degre
protect
rotaviru
infect
vesikari
et
al
dennehi
glass
et
al
nevertheless
report
despit
wide
coverag
antibodi
induc
vaccin
total
prevent
symptomat
infect
rotaviru
genotyp
bucardo
et
al
find
impli
new
gener
vaccin
complementari
prevent
approach
need
decreas
morbid
mortal
associ
rotaviru
diarrhea
demirjian
levi
glass
et
al
last
year
research
focus
potenti
use
probiot
prevent
agent
rotaviru
food
agricultur
organ
fao
world
health
organ
defin
probiot
live
microorgan
administ
adequ
amount
confer
health
benefit
host
faowho
microorgan
demonstr
effect
prevent
sever
disord
infect
diarrhea
inflammatori
diseas
reid
kotzampassi
giamarellosbourbouli
moreov
probiot
affect
modul
establish
intestin
microbiota
enhanc
matur
innat
adapt
immun
system
among
other
kotzampassi
giamarellosbourbouli
regard
efficaci
microorgan
treat
rotavirusrel
diarrhea
number
probiot
report
includ
bifidobacterium
longum
lactobacillu
acidophilu
strain
lee
et
al
commerci
probiot
strain
lactobacillu
gg
sindhu
et
al
nevertheless
report
base
amelior
diarrhea
symptom
littl
publish
identif
mechan
molecul
underli
rotaviru
inhibit
respect
current
idea
regard
mechan
action
includ
chang
gut
ecolog
effect
gut
mucos
barrier
modul
immun
respons
kotzampassi
giamarellosbourbouli
strainspecif
oelschlaeg
previou
studi
demonstr
strain
b
longum
subsp
infanti
cect
exert
direct
vitro
effect
rotaviru
infect
cell
line
et
al
furthermor
vivo
effect
shown
involv
antivir
effect
immunolog
enhanc
provid
preliminari
protect
rotaviru
infect
mous
model
strain
also
character
demonstr
b
longum
subsp
infanti
cect
fulfil
main
criteria
requir
consider
probiot
howev
interact
probiot
host
cell
surfac
alon
explain
mechan
involv
sinc
infect
level
decreas
even
probiot
ad
directli
viru
therefor
studi
must
conduct
establish
mechan
involv
antivir
effect
probiot
strain
thu
aim
studi
identifi
molecul
directli
respons
activ
strain
b
longum
subsp
infanti
cect
rotaviru
investig
mechan
underli
inhibit
human
colon
carcinoma
cell
line
grown
dulbecco
modifi
minim
essenti
medium
dmem
supplement
vv
et
al
assay
carri
et
al
competit
assay
perform
rotaviru
ito
wa
cell
line
case
cell
monolay
grown
plate
test
compound
incub
rotaviru
follow
infect
cell
viruscompound
mixtur
strategi
compound
incub
cell
cultur
follow
inocul
viru
strategi
b
case
viral
antigen
detect
immunoperoxidas
assay
et
al
infecti
peroxidasestain
foci
count
arithmet
mean
calcul
determin
number
foci
per
microscop
field
compar
number
infecti
foci
untreat
viru
control
obtain
reduct
percentag
viru
focusform
unit
identifi
peptid
synthes
puriti
genscript
corpor
piscataway
nj
usa
activ
measur
strategi
differ
concentr
purif
identif
substanc
interest
cation
exchang
chromatographi
follow
reversephas
chromatographi
volum
l
cultur
strain
b
longum
subsp
infanti
cect
grow
mr
de
man
rogosa
sharp
oxoid
basingstok
uk
medium
supplement
cystein
wv
mrsc
obtain
centrifug
g
min
c
supernat
neutral
ph
naoh
concentr
freezedri
steril
filter
minisart
hydrophil
syring
filter
sartoriu
stedim
biotech
gmbh
gottingen
germani
concentr
supernat
store
c
use
order
studi
natur
substanc
interest
freezedri
sampl
treat
lipas
proteas
proteinas
k
pepsin
studi
effect
lipas
freezedri
sampl
ml
supernat
resuspend
ml
phosphat
buffer
solut
mm
ph
ml
lipas
porcin
pancrea
ad
mgml
sigmaaldrich
mixtur
incub
c
h
reaction
inactiv
take
solut
ph
regard
pepsin
freezedri
sampl
ml
supernat
resuspend
ml
mcilvain
buffer
mm
ph
ml
pepsin
solut
ad
mgml
sigmaaldrich
st
loui
mo
usa
mixtur
incub
c
h
reaction
inactiv
take
solut
ph
final
volum
ml
case
proteinas
k
freezedri
sampl
ml
supernat
resuspend
ml
phosphat
buffer
mm
ph
ml
proteinas
k
solut
ad
mgml
sigmaaldrich
mixtur
incub
c
h
proteinas
k
inactiv
incub
c
min
analysi
inhibit
prolifer
rotaviru
perform
process
supernat
neg
control
includ
test
supernat
cultur
medium
mrsc
without
inocul
supernat
incub
h
c
control
noninactiv
proteinas
k
supernat
could
test
due
postincub
cell
lysi
neg
control
inhibit
nonfer
freezedri
sampl
use
posit
control
infect
solut
contain
cell
virus
use
purif
perform
follow
chenol
et
al
briefli
supernat
ad
sodium
phosphat
buffer
mm
ph
appli
cation
exchang
column
hiprep
sp
ff
ge
healthcar
amersham
bioscienc
ab
sweden
mean
chromatographi
system
explor
amersham
pharmacia
biotech
protein
cation
natur
adsorb
elut
sodium
phosphat
buffer
mm
ph
equilibr
nacl
without
gradient
protein
elut
simultan
fraction
minim
volum
ml
collect
fraction
subject
ultrafiltr
process
use
da
filter
extrem
amicon
millipor
billerica
usa
follow
anoth
stage
revers
phase
chromatographi
resourc
rpc
ml
column
ge
healthcar
aliquot
fraction
taken
dryness
elimin
dissolv
resuspend
volum
mem
buffer
sigmaaldrich
perform
vitro
inhibit
assay
total
fraction
select
rotaviru
inhibit
assay
strategi
b
viru
cell
line
explain
fraction
gave
posit
inhibit
result
analyz
malditof
peptid
mass
fingerprint
centro
nacion
de
investigacion
cardiovascular
cnic
madrid
spain
determin
molecular
weight
peptid
present
fraction
sequenc
obtain
compar
databas
proteinspeptid
mean
blast
onlin
tool
volum
l
cultur
strain
b
longum
subsp
infanti
cect
mrsc
medium
obtain
centrifug
g
min
refriger
condit
protein
precipit
addit
ammonium
sulfat
satur
collect
centrifug
min
g
pellet
resuspend
trishcl
buffer
trishcl
mm
ph
dialyz
kda
membran
c
appli
anion
exchang
column
hiprep
q
xl
ge
healthcar
mean
chromatograph
system
explor
anion
protein
elut
buffer
trishcl
ph
cacl
mm
use
gradient
nacl
indic
purif
process
sampl
monitor
nm
throughout
elut
proteas
activ
measur
bsa
substrat
follow
bradford
proteaseposit
fraction
concentr
kda
ultrafiltr
millipor
dilut
distil
water
appli
gel
filtrat
chromatographi
column
volum
hiload
superdex
prep
grade
column
ge
healthcar
europ
gmbh
barcelona
spain
fraction
rang
da
sampl
monitor
absorb
nm
fraction
protein
collect
desalt
column
ge
healthcar
life
scienc
concentr
kda
ultrafiltr
volum
proteaseposit
fraction
electrophores
polyacrylamid
sdspage
gel
gel
stain
silver
nitrat
kda
commerci
molecular
weight
marker
sdspage
standard
broad
rang
use
singl
band
separ
analyz
malditof
peptid
mass
fingerprint
cnic
determin
molecular
weight
sequenc
protein
sequenc
obtain
compar
databas
proteinspeptid
mean
blast
onlin
tool
order
evalu
whether
purifi
proteas
hydrolyz
protein
obtain
peptid
enzymat
activ
assay
perform
substrat
purifi
proteas
cect
supernat
enzym
hydrolysi
carri
solut
contain
ml
proteasepurifi
fraction
u
ml
solut
bioultra
sigmaaldrich
ml
phosphat
citrat
buffer
mm
ph
h
hydrolysi
c
sampl
boil
min
peptid
format
analyz
hplc
evalu
format
degrad
conduct
hplc
water
photodiod
array
detector
water
column
sunfir
water
mm
mm
eluent
water
milliq
qualiti
acetonitril
vv
b
tfa
vv
chromatograph
condit
summar
tabl
character
purifi
proteas
proteas
activ
assay
supernat
strain
cect
grown
mrsc
media
contain
glucos
lactos
maltos
sole
carbon
sourc
respect
gl
proteas
activ
measur
supernat
h
growth
centrifug
g
min
refriger
condit
bsa
degrad
wv
citratephosph
buffer
mm
ph
measur
differ
incub
time
h
h
h
supernat
kda
concentr
fraction
use
supernat
kda
concentr
fraction
enzymat
reaction
perform
substrat
assay
perform
describ
degrad
format
monitor
hplc
proteas
assay
perform
differ
ph
valu
purifi
proteas
solut
wv
incub
purifi
proteas
c
optimum
temperatur
h
hydrolysi
reaction
carri
solut
purifi
proteas
ml
solut
wv
ml
pb
buffer
ml
ph
incub
sampl
boil
min
stop
reaction
filter
millipor
pores
filter
peptid
analyz
hplc
proteas
assay
perform
purifi
proteas
differ
temperatur
degrad
assay
carri
h
ph
temperatur
c
case
ph
studi
amount
peptid
analyz
hplc
influenc
zinc
potassium
calcium
purifi
proteas
activ
studi
assay
carri
wv
substrat
citratephosph
buffer
ph
mm
incub
condit
c
optimum
temperatur
h
miner
ad
separ
final
concentr
mm
incub
sampl
boil
pores
filter
analyz
hplc
control
includ
without
addit
miner
case
result
obtain
analyz
use
graphpad
prism
softwar
graphpad
softwar
la
jolla
ca
usa
data
subject
oneway
analysi
varianc
anova
tukey
multipl
comparison
test
use
comparison
mean
purif
identif
substanc
interest
cation
exchang
follow
reversephas
chromatographi
identif
natur
activ
compound
order
determin
natur
activ
compound
respons
inhibit
rotaviru
freezedri
sampl
treat
proteinas
k
pepsin
lipas
nontreat
cect
supernat
significantli
decreas
infect
via
either
strategi
b
respect
strategi
use
identifi
activ
substanc
rotaviru
start
purif
cect
activ
supernat
total
fraction
revers
phase
select
rotaviru
inhibit
assay
strategi
b
six
fraction
render
signific
reduct
infect
foci
select
investig
select
fraction
summar
tabl
fraction
prove
posit
inhibit
analyz
malditof
peptid
mass
fingerprint
determin
molecular
weight
peptid
present
fraction
result
fraction
shown
analyz
spectra
common
signal
result
averag
least
two
independ
experi
sd
standard
deviat
pvalu
b
pvalu
select
fraction
correspond
peptid
molecular
weight
da
identifi
molecul
potenti
activ
rotaviru
signal
identifi
de
novo
sequenc
result
peptid
acid
whose
sequenc
mhqphqplppt
name
peptid
whose
molecular
mass
da
figur
sequenc
check
data
base
proteinspeptid
mean
blast
onlin
tool
identifi
part
cow
milk
correspond
amino
acid
sequenc
posit
bo
tauru
genbank
access
gi
order
determin
whether
peptid
respons
rotaviru
inhibit
assay
human
rotaviru
wa
ito
perform
cell
line
synthes
peptid
follow
strategi
test
compound
incub
rotaviru
prior
cell
infect
figur
b
cell
incub
test
compound
prior
cell
infect
figur
result
differ
case
viru
cell
line
gener
inhibit
percentag
higher
assay
perform
cell
line
take
account
peptid
concentr
inhibit
result
reach
plateau
lower
concentr
improv
higher
peptid
amount
result
may
due
potenti
format
peptid
aggreg
higher
concentr
lead
loss
function
depend
viru
cell
line
strategi
inhibit
obtain
assay
case
wa
viru
assay
highest
inhibit
percentag
foci
reduct
concentr
pvalu
case
ito
viru
foci
reduct
rang
cell
line
cell
follow
strategi
b
wa
ito
viru
infect
inhibit
cell
line
assay
highest
result
foci
reduct
concentr
wa
viru
cell
inhibit
obtain
wa
viru
inhibit
render
maximum
viru
concentr
foci
reduct
pvalu
figur
maldi
mass
spectrum
common
peptid
among
function
fraction
obtain
follow
purif
cation
exchang
chromatographi
frontier
microbiolog
wwwfrontiersinorg
human
rotaviru
prolifer
thought
inhibit
peptid
found
cow
milk
evalu
hypothet
mechan
wherebi
peptid
releas
potenti
supernat
proteas
activ
hydrolys
casein
present
mr
broth
check
hypothesi
strategi
adopt
purifi
identifi
potenti
enzym
first
supernat
chromatograph
purifi
final
proteaseposit
fraction
electrophores
singl
kda
band
present
sdspage
gel
separ
analyz
malditof
peptid
mass
fingerprint
band
identifi
maletyp
abc
sugar
transport
system
periplasm
compon
highest
homolog
sequenc
gi
maletyp
abc
sugar
transport
system
periplasm
compon
b
longum
molecular
weight
kda
order
evalu
format
peptid
activ
purifi
proteas
hydrolysi
assay
perform
use
purifi
proteas
enzym
substrat
h
hydrolysi
peptid
quantif
hplc
show
effici
peptideml
purifi
proteas
character
term
carbon
sourc
ph
temperatur
cofactor
proteas
activ
b
longum
cect
supernat
media
contain
glucos
lactos
maltos
sole
carbon
sourc
shown
tabl
result
averag
least
two
differ
experi
sd
standard
deviat
nt
test
pvalu
b
pvalu
c
pvalu
case
signific
higher
activ
found
supernat
probiot
strain
b
longum
cect
grown
presenc
maltos
supernat
render
highest
valu
h
incub
media
maltos
activ
muml
pvalu
regard
purifi
fraction
activ
valu
around
time
higher
maximum
muml
activ
h
incub
pvalu
tabl
summar
peptid
quantif
obtain
supernat
concentr
fraction
incub
substrat
result
rang
peptideml
highest
valu
correspond
supernat
fraction
obtain
growth
probiot
cect
maltos
sole
carbon
sourc
peptideml
respect
result
regard
effect
ph
temperatur
product
purifi
proteas
summar
tabl
maximum
peptid
concentr
valu
obtain
ph
signific
differ
obtain
ph
regard
optimum
reaction
temperatur
valu
obtain
rang
peptideml
signific
differ
found
maximum
concentr
peptid
obtain
c
activ
found
c
order
character
purifi
proteas
thoroughli
analyz
influenc
zinc
potassium
calcium
cofactor
format
result
shown
tabl
rang
peptideml
highest
valu
correspond
assay
without
miner
addit
ph
c
nd
data
averag
least
two
independ
experi
nd
detect
control
miner
addit
data
averag
least
two
independ
experi
sd
standard
deviat
pvalu
b
pvalu
recent
clinic
trial
demonstr
probiot
strain
abl
amelior
acut
rotavir
diarrhea
grandi
et
al
lee
et
al
assum
gut
microbiota
balanc
enhanc
mucos
barrier
modul
immun
respons
afford
protect
rotaviru
diarrhea
kotzampassi
giamarellosbourbouli
howev
studi
investig
mechan
underli
protect
effect
probiot
rotaviru
previou
work
demonstr
direct
effect
strain
b
longum
subsp
infanti
cect
rotaviru
replic
et
al
likewis
lee
et
al
found
b
longum
ibg
l
acidophilu
la
strongli
inhibit
rotaviru
infect
use
vero
cell
line
identifi
mechan
anoth
studi
maragkoudaki
et
al
investig
induct
noand
h
reactiv
oxygen
speci
ro
releas
cell
line
coincub
lactic
acid
bacteria
result
strain
cell
line
specif
data
report
probiot
block
viral
attach
competit
inhibit
abl
bind
viral
receptor
surfac
intestin
cell
et
al
studi
systemat
approach
taken
identifi
molecul
directli
involv
rotaviru
inhibit
first
determin
natur
substanc
interest
supernat
without
enzymat
treatment
analyz
function
assay
high
percentag
inhibit
nontreat
cellfre
supernat
suggest
part
activ
cect
strain
rotaviru
directli
exert
cell
molecul
respons
direct
rotaviru
inhibit
releas
supernat
previous
hypothes
probiot
strain
et
al
assay
perform
identifi
natur
function
compound
treatment
differ
proteas
elimin
inhibit
capac
confirm
proteinac
natur
substanc
respons
inhibit
rotaviru
infect
similar
assay
appli
lipas
inhibit
capac
reduc
data
shown
refut
potenti
lipid
natur
substanc
interest
direct
effect
differ
compound
polyphenol
kwon
et
al
theaflavin
clark
et
al
rotaviru
report
previous
howev
role
play
molecul
proteinac
natur
rotaviru
poorli
describ
literatur
frequent
report
protein
lactoferrin
confer
least
part
antivir
properti
breast
milk
van
der
strate
et
al
prevent
adsorpt
rotaviru
target
cell
due
capac
bind
viru
particl
superti
et
al
confirm
proteinac
natur
substanc
act
rotaviru
went
identifi
activ
compound
perform
supernat
purif
strategi
base
cation
exchang
chromatographi
strategi
carri
success
purifi
probiot
antibacteri
compound
follow
strategi
fraction
cation
natur
obtain
base
inhibit
rotaviru
infect
six
fraction
posit
thu
select
malditof
analysi
spectra
point
one
function
compound
acid
peptid
common
posit
fraction
peptid
part
cow
milk
molecular
mass
kda
order
verifi
function
peptid
inhibit
assay
run
synthes
peptid
wa
ito
rotaviru
use
cell
line
result
similar
previous
publish
probiot
b
longum
cect
et
al
reach
maximum
infecti
foci
inhibit
clearli
confirm
peptid
respons
rotaviru
inhibit
report
direct
activ
peptid
rotaviru
scarc
ijaz
et
al
found
synthet
peptid
directli
inhibit
rotaviru
studi
hypothes
block
receptor
site
host
cell
studi
kvistgaard
et
al
bojsen
et
al
found
bovin
macromolecular
whey
protein
may
exert
vitro
vivo
inhibitori
activ
rotaviru
major
compon
bovin
igg
regard
lactoferrin
peptid
report
superti
et
al
use
differ
peptid
come
artifici
hydrolyz
lactoferrin
demonstr
peptid
abl
interfer
differ
stage
viru
replic
import
specif
recognit
event
regard
casein
sourc
antivir
activ
previou
work
bovin
milk
demonstr
antivir
activ
human
rotaviru
conclud
inhibitori
mechan
bovin
human
rotaviru
involv
direct
bind
viral
particl
via
glycan
residu
inagaki
et
al
case
peptid
contain
glycan
residu
furthermor
antivir
activ
conserv
synthes
peptid
glycan
residu
therefor
anoth
mechan
must
involv
activ
rotaviru
fact
peptid
effect
assay
carri
strategi
b
found
differ
sensit
depend
viru
cell
line
strongli
suggest
twoway
effect
interact
peptid
mammalian
cell
surfac
directli
viru
must
play
role
inhibit
mechan
hypothes
previous
et
al
moreov
posit
result
obtain
even
low
peptid
concentr
show
peptid
exert
strong
activ
identifi
sourc
peptid
analysi
experiment
data
lead
us
hypothes
secondari
origin
peptid
deriv
preliminari
digest
casein
present
commerci
mr
growth
medium
use
proteas
secret
probiot
strain
b
longum
subsp
infanti
cect
may
releas
peptid
hydrolyz
casein
present
cultur
mechan
function
molecul
releas
casein
previous
describ
janer
et
al
b
animali
subsp
lacti
speci
author
describ
zinc
metallopeptidas
pepo
abl
hydrolyz
casein
suggest
play
role
increas
growth
b
animali
subsp
lacti
milk
accordingli
perform
purif
identif
proteas
respons
product
obtain
proteas
appli
strategi
base
fraction
anion
chromatographi
follow
protocol
proteaseposit
anion
extract
obtain
sdsgel
band
confirm
uniqu
band
malditof
peptid
mass
fingerprint
analysi
identifi
purifi
proteas
maletyp
abc
sugar
transport
system
periplasm
compon
periplasm
bind
protein
part
maltos
abc
sugar
transport
system
involv
transport
maltos
maltodextrin
although
preliminari
studi
compon
perform
salmonella
enterica
subsp
enterica
serovar
typhimurium
escherichia
coli
review
ehrmann
et
al
found
bacteria
includ
bifidobacteria
assembl
b
animali
subsp
lacti
assembl
b
longum
data
obtain
whole
genom
sequenc
b
longum
cect
strain
chenol
et
al
genom
refer
protein
identifi
genom
molecular
weight
kda
confirm
protein
produc
probiot
strain
identifi
maletyp
abc
sugar
transport
system
periplasm
compon
character
term
proteas
activ
result
obtain
inhibit
studi
glucos
lactos
maltos
supernat
show
highest
activ
probiot
grown
maltos
carbon
sourc
moreov
maltosegrown
purifi
fraction
around
time
higher
maximum
mu
ml
activ
result
togeth
quantif
peptid
supernat
fraction
incub
confirm
proteas
activ
enhanc
maltos
sole
carbon
sourc
support
identif
maletyp
abc
sugar
transport
system
periplasm
compon
molecul
respons
proteas
activ
although
proteas
activ
male
describ
previous
data
point
mechan
wherebi
format
peptid
caus
direct
action
purifi
protein
effici
reaction
final
optimum
ph
temperatur
purifi
proteas
activ
establish
influenc
zinc
potassium
calcium
cofactor
product
discard
knowledg
first
report
mechan
probiot
produc
function
molecul
exert
direct
activ
rotaviru
mode
action
support
potenti
use
strain
cect
dairi
infant
formula
function
peptid
would
produc
probiot
cow
milk
summari
result
present
first
identifi
natur
produc
peptid
mhqphqplppt
molecul
directli
respons
rotaviru
inhibit
demonstr
probiot
b
longum
subsp
infanti
cect
data
report
point
mechan
base
maletyp
abc
sugar
transport
system
periplasm
compon
abl
exert
proteas
activ
hydrolyz
produc
function
peptid
ec
design
experi
particip
assay
hydrolyz
fraction
identif
supernat
molecul
proteas
antirotavir
activ
contribut
dataanalysi
write
bc
particip
experi
eb
particip
hydrolyz
supernat
fraction
identif
proteas
experi
jb
design
coordin
viru
experi
contribut
dataanalysi
write
dr
design
coordin
supernat
proteas
experi
contribut
dataanalysi
write
sg
design
coordin
proteas
supernat
experi
contribut
dataanalysi
write
jf
contribut
dataanalysi
write
mr
particip
design
experi
contribut
dataanalysi
write
jm
design
research
plan
organ
studi
contribut
dataanalysi
write
studi
support
ministerio
de
industria
turismo
comercio
grant
profit
european
social
fund
grant
jm
cofund
icrea
junior
empresa
grant
catalonia
spain
